← All organizations
Highest phase reached
Phase 3
First clinical trial
Mar 1, 2000First marketed drug
Mar 6, 2012First NDA
Mar 6, 2012Last known activity
Dec 1, 2023
Timeline
1990s
- Nov 1, 1992
Windtree Therapeutics— Founded
2010s
- Mar 6, 2012
lucinactant— NDA Organization
- Mar 6, 2012
lucinactant— NDA Secondary Org
- Dec 21, 2018
CVie Therapeutics Co. Ltd.— Acquired
Drugs by trial phase (10 distinct, 18 trials)
Phase 4 (0 own, 1 via acquisition)
Phase 3 (4 own, 0 via acquisition)
Phase 2 (1 own, 3 via acquisition)
Phase 1 (0 own, 1 via acquisition)
Indications
Marketed drugs (1)
Subsidiaries (1 direct, 1 total across the full acquisition tree)
Recent trials (21)
- NCT05975021Study directorPhase 1/Phase 2Dec 1, 2023
- NCT05975021Lead sponsorPhase 1/Phase 2Dec 1, 2023
- NCT04325035Lead sponsorPhase 2Jun 30, 2020
- NCT04389671Lead sponsorPhase 1/Phase 2Jun 1, 2020
- NCT04264156Lead sponsorPhase 2Mar 1, 2020
- NCT04264156Overall official - principal investigatorPhase 2Mar 1, 2020
- NCT02636868Study directorPhase 2Dec 1, 2015
- NCT02636868Lead sponsorPhase 2Dec 1, 2015
- NCT02528318Study directorPhase 2Aug 1, 2015
- NCT02528318Lead sponsorPhase 2Aug 1, 2015
- NCT02074059Lead sponsorPhase 2Feb 1, 2014
- NCT02074059Overall official - principal investigatorPhase 2Feb 1, 2014
- NCT00934362CollaboratorPhase 2Oct 1, 2008
- NCT00578734Lead sponsorPhase 2Jun 1, 2007
- NCT00215540Study directorPhase 2Feb 1, 2005
Details
- Founded
- Warrington, PA, US Nov 1, 1992
- First NDA
- Mar 6, 2012
- Last known activity
- Dec 1, 2023
Designations held
- Fast track